| Chronic Lymphocytic Leukemia B Cells Express Functional CXCR4 Chemokine Receptors That Mediate Spontaneous Migration Beneath Bone Marrow Stromal Cells | Blood | 1999 | 391 |
| Transient excess of MYC activity can elicit genomic instability and tumorigenesis | Proceedings of the National Academy of Sciences of the United States of America | 1999 | 370 |
| Development of difluoromethylornithine (DFMO) as a chemoprevention agent | Clinical Cancer Research | 1999 | 215 |
| Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells | Blood | 1999 | 176 |
| Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice | Proceedings of the National Academy of Sciences of the United States of America | 1999 | 102 |
| Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia | American Journal of Hematology | 1999 | 76 |
| Methylation of p16INK4A in primary gynecologic malignancy | Cancer Letters | 1999 | 69 |
| The influence of a low-fat diet on incidence and severity of migraine headaches | Journal of Women's Health and Gender-Based Medicine | 1999 | 55 |
| A new era for radiolabeled antibodies in cancer? | Current Opinion in Immunology | 1999 | 53 |
| Myeloid Malignancies Induced by Alkylating Agents in Nf1 Mice | Blood | 1999 | 46 |
| Embolization and chemoembolization therapy for neuroendocrine tumors | Current Opinion in Oncology | 1999 | 45 |
| Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells | Cancer Gene Therapy | 1999 | 30 |
| Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma | International Journal of Cancer | 1999 | 28 |
| Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro | Cancer Research | 1999 | 27 |
| Treatment Options in Androgen-Independent Prostate Cancer | Cancer Investigation | 1999 | 26 |
| Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination | AIDS Research and Human Retroviruses | 1999 | 23 |
| Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A | Clinical Cancer Research | 1999 | 23 |
| Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP) | Oncogene | 1999 | 22 |
| Critical Lym-1 binding residues on polymorphic HLA-DR molecules | Molecular Immunology | 1999 | 22 |
| A model-based approach for assessing in vivo combination therapy interactions | Proceedings of the National Academy of Sciences of the United States of America | 1999 | 18 |
| Anti-HER2 immunoliposomes for targeted drug delivery | Annals of the New York Academy of Sciences | 1999 | 16 |
| Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation | Journal of Virology | 1999 | 16 |
| Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines | Journal of General Virology | 1999 | 16 |
| Sequential chemotherapy: rationale and clinical trial design in advanced non-small-cell carcinoma | Clinical Lung Cancer | 1999 | 15 |
| Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient | Gynecologic Oncology | 1999 | 14 |
